Biotech stocks have swung sharply higher, buoyed by several factors. Could they be poised to lead the market though the next big upturn?
In this article, we discuss the top 10 stock picks of Roberto Mignone’s Bridger Management. If you want to skip our detailed analysis of Mignone’s history, investment philosophy, and hedge fund performance, go directly to Top 5 Stock Picks of Roberto Mignone’s Bridger Management. Roberto Mignone established Bridger Management in the year 2000. He pursued […]
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that the Institute for Clinical and Economic Review (ICER) released a Draft Evidence Report updating the previous Hemophilia A assessment of the comparative clinical effectiveness and value of ROCTAVIAN ™ (valoctocogene roxaparvovec).